Update on Monitoring & Electronic Medical Records at UCSF
|
|
- Gertrude Gibbs
- 8 years ago
- Views:
Transcription
1 Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Update on Monitoring & Electronic Medical Records January 10, 2012 at UCSF Danusia Filipowski, MD Director, CRC-Core UCSF CTSI Filipowskid@gcrc.ucsf.edu 415/
2 This discussion will include: Certified Medical Records Clinical i l Research & Medical Records in APEX
3 Let s begin by reviewing some definitions 1. Def: Source Documents Describes the types of records that we routinely find being used to document events that occur during the conduct of clinical trials. This includes: Original documents, data and records. EXAMPLES of some types of records: hospital records subjects' diaries memoranda Clinical and office charts evaluation checklists laboratory notes X-rays &Oth Other images pharmacy dispensing i recorded d data from records automated instruments reports copies or transcriptions after verification as being accurate and complete microfilm or magnetic media records kept at the pharmacy records kept at the lab Photographic negatives FDA's ICH E6 Good Clinical Practice: Consolidated Guidance (
4 2. Def: Copies The use of copies as described in the ICH guidance, generally applies to situations where original records are copied to a different media for archiving purposes and the originals are destroyed.
5 3. Def: Certified Medical Record A copy of Patient s medical records authenticated, as an accurate and complete representation of the original, having all of the same attributes and information, by the licensee or health care facility, as appropriate. (page 112) the FDA accepts, as equivalent to the original source document, copies or transcriptions certified after verification as being accurate and complete. This process produces what is known as a "certified copy". A certified copy is one that preserves all of the attributes of the original source document and that is dated and signed as a testament/documentation that the copy of the document is an exact copy of the Patricia M. Beers Block Good Clinical Practice Program (HF-34) Office of Science and Health Coordination Office of the Commissioner/ FDA 5600 Fishers Lane, Rm. 14B17 Rockville, MD :301/
6 How To Certifying a Medical Record The FDA & various sponsors agree that there are many ways to certify a record. The process can vary from site to site The following are the key steps:
7 How to Certify a Medical Record STEP 1: 1If it is decided to have a certified copy substitute for the original, it would be desirable to have an SOP describing how such copies would be made, verified and documented. It should explain where the medical records are located (in hard copy medical record chart or source research shadow chart).
8 Some sites use tools like these Some sites use tools like these charts to indicate how & where records will be kept. This is part of the SOP.
9 How to Certify a Medical Record STEP 2: 1. 2 The person who certifies the copy as an accurate and complete representation of the original, having all of the same attributes and information, should be the same person who actually made the copy from the original.
10 How to Certify a Medical Record STEP 3: Certification can be accomplished by initialing and dating each copy or by initialing and dating a document certifying copies in bulk. Many UCSF sites use a Certified stamp to stamp, date and initial each page of the medical record that is copied. Another option is to use a Form to certify the packet of copies.
11 This is a This is a sample form from a sponsor
12 This is a sample form from the CA Medical Board site I do not have permission to copy this form. Please see the website below to view.
13 Take home message is: Set up a process now and follow it. This will show due diligence, that the PI is providing the complete medical record for research monitoring.
14 What does the FDA say about Copies of Electronic Records? we recommend that the copying process used produces copies that preserve the content t and meaning of the record. Title 21 CFR Part 11, Electronic Records; Electronic Signatures Scope and Application
15 How will APEX change all this? The processes have not been finalized, but we are working to attain the following: 1 To provide monitors/auditors electronic accounts for temporary use, with limited access to medical data 2 All data from STOR, and Ucare will be transferred into APEX, so there will be fewer sources of data 3 All consents/assents and HIPAA documents will be scanned into APEX
16 How will APEX change all this? Some of the unanswered questions: 1Will monitors need to renew access before each visit? How long will their access be good for? Will they see all records related to a patient or just those related to the study, and if the records are limited who will set the parameters? 2.. 3If the consents/assents and HIPAA will all be store in APEX, will original signed consents still be required?
17 What are your questions? If you have specific questions that were not addressed here please me at: Danusia Filipowski, MD Perhaps your questions will be the subject of our next seminar we are always looking for new topics that are of interest to you.
STANDARD OPERATING PROCEDURE FOR DATA RETENTION
STANDARD OPERATING PROCEDURE FOR DATA RETENTION SOP Number: GCP DM 505.02 Version Number & Date: 2 nd Version; 25 Apr 2013 Superseded Version Number & Date (if applicable): 1 st Version; 17 June 2010 Effective
More informationGuidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
More informationElectronic Medical Records and Source Data for Research: What s the Difference?
Electronic Medical Records and Source Data for Research: What s the Difference? Tammy Anderson, CCRC, CCRA, CRCP Director, Clinical Trials Office Virginia Commonwealth University Research Coordinator 4
More informationNova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1
Nova Southeastern University Standard Operating Procedure for GCP Title: Electronic Source Documents for Clinical Research Study Version # 1 SOP Number: OCR-RDM-006 Effective Date: August 2013 Page 1 of
More informationGuidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS U.S. Department of Health and Human Services Food and Drug Administration Center for Biologic Evaluation and Research (CBER) Center for
More informationROLE OF THE RESEARCH COORDINATOR
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Data Collection
More informationROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
More informationGuidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More informationGCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
More informationGuidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for
More informationUse of Electronic Health Record Data in Clinical Investigations
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationGood Documentation Practices
Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the
More informationComparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Document issued on: June 2004 U.S. Department of Health and Human Services Food and Drug Administration
More informationReflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials
09 June 2010 EMA/INS/GCP/454280/2010 GCP Inspectors Working Group (GCP IWG) Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationThis SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.
Standard Operating Procedure: SOP Number: SOP-QA-32 Version No: 1 Author: Date: (Gary Cooper, Named Sponsor Archivist, NHS Grampian and University of Aberdeen) 1-9-15 Approved by: Date: 1-9-15 (Professor
More informationMedical Record Documentation
Good Clinical Practice & Medical Record Documentation Hanne Baekgaard Larsen & Terri Halverson Objectives: Understand the history behind and define some key components of Good Clinical Practice Identify
More informationSupplement to the Guidance for Electronic Data Capture in Clinical Trials
Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Note: The original language of this
More informationNo. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
More informationGuidance for Industry. IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations
Guidance for Industry IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations FINAL This guidance is being distributed GUIDANCE for immediate implementation. FDA is issuing this guidance for
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationDocument Control SOP. Document No: SOP_0103 Prepared by: David Brown. Version: 10
1.0 Commercial in Confidence 16-Aug-2006 1 of 6 Document Control SOP Document No: SOP_0103 Prepared by: David Brown Date: 16-Aug-2006 Version: 10 1.0 Commercial in Confidence 16-Aug-2006 2 of 6 Document
More informationAuditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories
Auditing Chromatographic Electronic Data Jennifer Bravo, M.S. QA Manager Agilux Laboratories Outline Raw data paper or electronic record? Controls for electronic data Auditing electronic records Warning
More informationDATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS
Reference Number: UHB 139 Version Number: 2 Date of Next Review: 14 Apr 2018 Previous Trust/LHB Reference Number: N/A DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Introduction and Aim
More informationSTANDARD OPERATING PROCEDURE FORMAL COVERAGE ANALYSIS
PURPOSE Establish a consistent comprehensive coverage analysis process that is well defined and performed on every clinical trial. UCSF REQUIREMENT Effective 6/1/2013, a formal coverage analysis must be
More informationRemote Monitoring of Clinical Trials and EMRs
Remote Monitoring of Clinical Trials and EMRs Sandra SAM Sather, MS, BSN, CCRA, CCRC Vice-President Clinical Pathways LLC samsather@clinicalpathwaysresearch.com Lindsey Spangler, J.D. Associate Director,
More informationGuidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Time Stamps Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationRecord Custodian to Health Information Steward Best Practices in Record Retention, Storage, and Destruction
Record Custodian to Health Information Steward Best Practices in Record Retention, Storage, and Destruction Indian Health Services Health Information Management Meeting Sharon Lewis, MBA, RHIA, CHPS, CPHQ
More informationROLE OF THE RESEARCH COORDINATOR Recruitment of Subjects Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Recruitment
More informationObjectives. The Paper Tells the Story
Notes to File: An Auditor s Perspective Lorrie D. Divers, CCRP, RQAP-GCP Executive Director, Global Quality Assurance & Compliance ACM Medical Laboratory / ACM Global Central Laboratory Clinical Translation
More informationCoSign for 21CFR Part 11 Compliance
CoSign for 21CFR Part 11 Compliance 2 Electronic Signatures at Company XYZ Company XYZ operates in a regulated environment and is subject to compliance with numerous US government regulations governed
More informationPKI Adoption Case Study (for the OASIS PKIA TC) ClinPhone Complies with FDA Regulations Using PKIbased Digital Signatures
PKI Adoption Case Study (for the OASIS PKIA TC) ClinPhone Complies with FDA Regulations Using PKIbased Digital Signatures PKI Project Title Digital Signatures for ClinPhone Organisation concerned ClinPhone
More informationA ChemoMetec A/S White Paper September 2013
NucleoCounter NC-3000, NucleoView NC-3000 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11) A ChemoMetec A/S White Paper September 2013 ChemoMetec
More informationImplement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system.
21 CRF 11 Electronic Records and Signatures Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system. By Todd Duell What does Title 21 of the Code of Federal
More informationElectronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries
White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device
More informationSponsor Site Questionnaire FAQs Regarding Maestro Care
Sponsor Site Questionnaire FAQs Regarding Maestro Care Data Security and Validation 1. Are the electronic source documents or computer systems specific to the site and/or developed by the site? a. Developed
More informationClinical Data Interchange Standards Consortium Electronic Source Data Interchange (esdi) Group
Clinical Data Interchange Standards Consortium Electronic Source Data Interchange (esdi) Group Leveraging the CDISC Standards to Facilitate the use of Electronic Source Data within Clinical Trials Version
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationStandard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
More informationGuidance for Industry
#108 Guidance for Industry How to Register with the CVM Electronic Submission System To Submit Information in Electronic Format Using the FDA Electronic Submissions Gateway This version of the guidance
More informationData Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
More informationInformation Sheet Guidance for Sponsors, Clinical Investigators, and IRBs
Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA 1572) U.S. Department of Health and Human Services Food and Drug
More informationThe Impact of 21 CFR Part 11 on Product Development
The Impact of 21 CFR Part 11 on Product Development Product development has become an increasingly critical factor in highly-regulated life sciences industries. Biotechnology, medical device, and pharmaceutical
More informationRD SOP17 Research data management and security
RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director
More informationData Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
More informationContains Nonbinding Recommendations
Guidance for Industry and FDA Staff Laser Products Conformance with IEC 60825-1 and IEC 60601-2-22; Guidance for Industry and FDA Staff (Laser Notice No. 50) Document issued on June 24, 2007 This document
More informationHow Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
More informationData Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
More informationSelf-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures
Self-Assessment of eresearch Compliance with 21 CFR Part 11, Electronic Record; Electronic Signatures Subpart A General Provisions Sec. 11.1 Scope. (a) The regulations in this part set forth the criteria
More informationFDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
More informationGuidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
More informationDetermination of Regulatory Review Period for Purposes of Patent Extension; XARELTO
This document is scheduled to be published in the Federal Register on 05/29/2014 and available online at http://federalregister.gov/a/2014-12349, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationGuidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Maintenance of Electronic Records
Draft Guidance for Industry -- Not For Implementation Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Maintenance of Electronic Records Draft Guidance This guidance document
More informationAAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE
1 AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE Instructions Test Article means any drug, biological product,
More informationDAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans
CHANGE SUMMARY: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. Key changes to the policy require all sites to submit a bi-annual Clinical
More informationHow To Control A Record System
Thermo Scientific Qtegra Intelligent Scientific Data Solution (ISDS) Software for 21 CFR Part 11 Compliant Laboratories Technical Note 43106 Key Words Compliance, Electronic Records, 21 CFR Part 11 Goal
More informationSTANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE
STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE UNC OB/GYN (V.1) 9.1.2014 Page i TABLE OF CONTENTS INTRODUCTION. iii ABBREVIATIONS iv GLOSSARY v LISTING OF ATTACHMENTS.... xi I. 1.0 GENERAL ADMINISTRATION
More informationApplication Dates: February 15 th to March 30 th
Effective 3/12 to 3/13 Application Dates: February 15 th to March 30 th OHLONE COLLEGE (IN COOPERATION WITH DIABLO VALLEY COLLEGE, PLEASANT HILL) APPLICATION F ADMISSION TO THE RESPIRATY THERAPIST PROGRAM
More informationImplementation of 21CFR11 Features in Micromeritics Software Software ID
Implementation of 21CFR11 Features in Micromeritics Software Software ID PART 11 ELECTRONIC RECORDS; ELECTRONIC SIGNATURES Subpart A General Provisions Sec. 11.1 Scope. 11.2 Implementation. 11.3 Definitions.
More informationCONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
More informationDocument Management Policy and Procedure
Office of Research and Sponsored Programs Issued: January, 2008 PURPOSE This document outlines the policy and procedures governing the retention and destruction of records within the Office of Research
More informationWhat is your most significant accomplishment and how does this translate to the relevancy in today s business? (300 words max)
NATIONAL BLACK MBA ASSOCIATION, INC. SAN FRANCISCO CHAPTER 2015 Scholarship Instructions The organization provides more than half million dollars annually in scholarships to undergraduates, graduates and
More informationGuidance to Research Ethics Committees on Initial Facility Assessment
Guidance to Research Ethics Committees on Initial Facility Assessment Introduction One of the roles of a Research Ethics Committee is to provide an opinion on a proposed study, based on the suitability
More informationGuidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products
Guidance for Industry Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Small Entity Compliance Guide Written comments and suggestions may be
More informationIMP management at site. Dmitry Semenyuta
IMP management at site Dmitry Semenyuta TOP 5 FDA inspections finding 1999-2009 Center of Drug Evaluation and Research (CDER) Failure to follow the protocol Failure to keep adequate and accurate records
More informationThe Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
More informationGCP - Records Managers Association
GCP - Records Managers Association Guidance on the Scanning and Destruction of Paper Records 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 The introduction
More information1/30/2013. Agenda. Electronic Signatures/ Informed Consent
2013 UC Compliance & Audit Symposium Recordkeeping Matters: Part 11 Compliance Rachel Nosowsky ~ Acting Deputy General Counsel Rachel.Nosowsky@ucop.edu ~ (510) 987-9407 Agenda Electronic Signatures/Informed
More informationSolidWorks Enterprise PDM and FDA 21CFR Part 11
T E C H N I C A L P A P E R SolidWorks Enterprise PDM and FDA 21CFR Part 11 This Technical Paper discusses the technical solutions provided by SolidWorks Enterprise PDM to address the FDA 21 CFR Part 11
More informationInternal Control Deliverables. For. System Development Projects
DIVISION OF AUDIT SERVICES Internal Control Deliverables For System Development Projects Table of Contents Introduction... 3 Process Flow... 3 Controls Objectives... 4 Environmental and General IT Controls...
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More information21 CFR Part 11 Implementation Spectrum ES
21 CFR Part 11 Implementation Spectrum ES INFRARED SPECTROSCOPY T E C H N I C A L N O T E Introduction Compliance with 21 CFR Part 11 is mandatory for pharmaceutical companies and their suppliers to sell
More informationGuidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
More informationThe Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
More informationInfoCenter Suite and the FDA s 21 CFR part 11 Electronic Records; Electronic Signatures
InfoCenter Suite and the FDA s 21 CFR part 11 Electronic Records; Electronic Signatures Overview One of the most popular applications of InfoCenter Suite is to help FDA regulated companies comply with
More informationEstablishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)
Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director
More informationPre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
More informationDetermination of Regulatory Review Period for Purposes of Patent Extension;
This document is scheduled to be published in the Federal Register on 12/15/2015 and available online at http://federalregister.gov/a/2015-31400, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationGuidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects
Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationPHILIPPINE NURSES ASSOCIATION OF NORTHERN CALIFORNIA, INC.
PHILIPPINE NURSES ASSOCIATION OF NORTHERN CALIFORNIA, INC. PNANC NURSING STUDENT SCHOLARSHIP The Philippine Nurses Association of Northern California, Inc. (PNANC) promotes fellowship and unity among Filipino
More informationThe Global Guideline for GCP Audit
The Global Guideline for GCP Audit Author: JSQA: Hiroyasu Yamashita, e-mail: hiroyasu-yamashita@ds-pharma.co.jp Reviewed and Acknowledged by: BARQA: Patricia Fitzgerald, e-mail: Patricia.fitzgerald@adamas.co.uk
More information- 1 - First Time Pharmacy Managers (Revised 02/02/2011)
State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO
More informationLIFE CHIROPRACTIC COLLEGE WEST
LIFE CHIROPRACTIC COLLEGE WEST HEALTH CENTER 25001 INDUSTRIAL BLVD. HAYWARD, CA 94545 510-780-4567 Fax 510-780-4511 Nina Kempf (510) 780-4560 ~ Pre-graduate and Post-graduate Internship Program ~ Policies,
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationCollege of American Pathologists Laboratory Accreditation Program. Document Control Management
College of American Pathologists Laboratory Accreditation Program Document Control Management William Castellani, MD, FCAP Inter-Regional Commissioner Laboratory Accreditation Program September 19, 2007
More informationClinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good
More informationTeaching Credential Program Application Spring 2006
Teaching Credential Program Application Spring 2006 Deadline: October 19, 2005 PLEASE PRINT CLEARLY Name Last First Middle Maiden/Former Address Home Phone ( ) Street Unit/Space Include Area Code Work
More informationProgram Assistance Letter DOCUMENT NUMBER: PAL 2009 - XX
Program Assistance Letter DOCUMENT NUMBER: PAL 2009 - XX DOCUMENT NUMBER: 2009-05 DATE: May 1, 2009 DOCUMENT TITLE: New Requirements for Medical Malpractice Coverage Deeming under the Federally Supported
More informationDAIDS Bethesda, MD USA POLICY. Requirements for Clinical Quality Management Plans
NOTE: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. DAIDS has clearly stated the minimum requirements for the CQMP and provided examples
More informationCalifornia State Board of Pharmacy and Medical Board of California
California State Board of Pharmacy and Medical Board of California Transmission and Receipt of Electronic Controlled Substance Prescriptions Pursuant to DEA Interim Final Rule (IFR): Electronic Prescriptions
More informationEclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11)
Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) The title 21 code of federal regulations part 11 deals with an institutions
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationRECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
More informationGuidance for Industry
Guidance for Industry Charging for Investigational Drugs Under an IND Qs & As DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationTools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System. White Paper. By Frank Tontala
Tools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System White Paper By Frank Tontala Agilent Technologies Software & Informatics Life Sciences & Chemical Analysis Group
More informationObjectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials
Objectives Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Guidelines suggest that following the good clinical research practice of monitoring/auditing
More informationFamily Child Care Assistants: A Guide for Educators
Family Child Care Assistants: A Guide for Educators EEC regulations require that Licensed Family Child Care Educators only allow approved caregivers to participate in the care of Family Child Care children.
More informationELECTRONIC SIGNATURES AND MANAGEMENT OF ELECTRONICALLY SIGNED RECORDS
Commandant United States Coast Guard 2100 Second Street, S.W. STOP 7101 Washington, DC 20593-7101 Staff Symbol: CG-6 Phone: (202) 475-3518 Fax: (202) 475-3929 COMDTINST 5200.5 FEB 3 2011 COMMANDANT INSTRUCTION
More information